Understanding corticotropin releasing factor neurobiology: contributions from mutant mice

被引:38
作者
Contarino, A [1 ]
Heinrichs, SC [1 ]
Gold, LH [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
D O I
10.1054/npep.1999.0001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mice with transgenic expression or deletion of the CRF peptide, transgenic expression of the CRF-BP or deletion of specific CRF receptor subtypes exist and will be valuable for examining candidate mediators in animal model systems recapitulating a variety of normal function. In particular, results described in this review implicate CRF in acute emotional responses studied in animal models of anxiety and drug abstinence. CRF also appears to play a role in behavioral and physiological plasticity judging by alterations in HPA reactivity to stress, information processing and energy balance regulation in CRF mutant models. Accordingly, the creation of genetically engineered mice now permits the evaluation of contributory roles for several CRF-related gene products in the pathophysiology of a variety of complex behavioral disorders. For example, the postulated causal linkage between overactivation of CRF systems and the hyper-emotionality which characterizes human affective disorders can now be more thoroughly evaluated by examining the phenotype of CRF mutant mice in animal models of depression, dementia and substance abuse.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 113 条
  • [1] Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence
    Adinoff, B
    Anton, R
    Linnoila, M
    Guidotti, A
    Nemeroff, CB
    Bissette, G
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 15 (03) : 288 - 295
  • [2] ANTIDEPRESSANTS AND COGNITION - COMPARATIVE EFFECTS OF MOCLOBEMIDE, VILOXAZINE AND MAPROTILINE
    ALLAIN, H
    LIEURY, A
    BRUNETBOURGIN, F
    MIRABAUD, C
    TREBON, P
    LECOZ, F
    GANDON, JM
    [J]. PSYCHOPHARMACOLOGY, 1992, 106 : S56 - S61
  • [3] CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT
    BALDWIN, HA
    RASSNICK, S
    RIVIER, J
    KOOB, GF
    BRITTON, KT
    [J]. PSYCHOPHARMACOLOGY, 1991, 103 (02) : 227 - 232
  • [4] Banki C M, 1992, Eur Neuropsychopharmacol, V2, P107, DOI 10.1016/0924-977X(92)90019-5
  • [5] The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist
    Baram, TZ
    Chalmers, DT
    Chen, C
    Koutsoukos, Y
    DeSouza, EB
    [J]. BRAIN RESEARCH, 1997, 770 (1-2) : 89 - 95
  • [6] BEAULIEU S, 1994, ANN NY ACAD SCI, V746, P388
  • [7] Behan DP, 1996, BRAIN RES, V725, P263, DOI 10.1016/S0006-8993(96)00347-2
  • [8] Behan DP, 1996, MOL PSYCHIATR, V1, P265
  • [9] CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN - A PUTATIVE PERIPHERAL AND CENTRAL MODULATOR OF THE CRF FAMILY OF NEUROPEPTIDES
    BEHAN, DP
    POTTER, E
    SUTTON, S
    FISCHER, W
    LOWRY, PJ
    VALE, WW
    [J]. CORTICOTROPIN-RELEASING FACTOR AND CYTOKINES: ROLE IN THE STRESS RESPONSE: HANS SELYE SYMPOSIUM ON NEUROENDOCRINOLOGY AND STRESS, 1993, 697 : 1 - 8
  • [10] CRF AND RESTRAINT-STRESS DECREASE EXPLORATORY-BEHAVIOR IN HYPOPHYSECTOMIZED MICE
    BERRIDGE, CW
    DUNN, AJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) : 517 - 519